Clinical Trials in Ohio

Showing 12181-12200 of 17,983 trials

Study of SNX-5422 in TP53 Null Cancers

NCT02612285

SNX-5422 is a pro-drug of SNX-2112, a potent, highly selective, small-molecule inhibitor of the molecular chaperone heat shock protein 90 (Hsp90). Initial in vitro evidence supports that SNX-5422 may be active against TP53 null tumors irrespective of tumor type .

Cancer

Esanex Inc.1 participantsStarted Mar 2016

Scottsdale, Arizona, United States • Augusta, Georgia, United States • Detroit, Michigan, United States +2 more locations

COMPLETEDPhase 232 miles

Safety Evaluation of 3K3A-APC in Ischemic Stroke

NCT02222714

The purpose of this study was to evaluate the safety, pharmacokinetics (PK) and preliminary efficacy of multiple ascending intravenous doses of 3K3A-APC, a Recombinant Variant of Human activated protein C (APC), in in the treatment of acute ischemic stroke following treatment with recombinant tissue plasminogen activator (tPA), mechanical thrombectomy or both.

Ischemic Stroke

ZZ Biotech, LLC110 participantsStarted Oct 2014

Los Angeles, California, United States • Chicago, Illinois, United States • Kansas City, Kansas, United States +12 more locations

Study of SNX-5422 in TP53 Null Cancers

Safety Evaluation of 3K3A-APC in Ischemic Stroke

Find Trials by Condition in Ohio

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Global Non-interventional Heart Failure Disease Registry

Safety and Efficacy of Cariprazine in Schizophrenia

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

A Study of Enzastaurin in Participants With Follicular Lymphoma

Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

Safety Evaluation of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Stroke

HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder

Cohort B of the Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter

Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

Evaluation of the VEGA Knee System® Range of Motion

VIVO™ Accuracy Study

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer